SBIR/STTR Research Award

Differential Optical Rotation for Chiral Analysis

Award identifier e2afe4cd71fe303c9f8e9dac1680aef21b0462b2737f17e8c43a966fe996d8d6Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$382,586

Program and phase

SBIR · Phase II

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
STHENO CORPORATION
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Many diseases are still without an effective treatment today, and others have evolved resistances requiring new therapeutic agents to be developed. In the effort to develop discovery candidates for medical applications, an important observation is that the vast majority of useful drugs contain one or several chiral centers. Since the wrong enantiomer can cause harmful side effects, very high enantiomeric purity of therapeutics is essential for safe and effective treatment. Thus, both producing enantiomerically pure formulations and testing for enantiomeric purity are critical. Unfortunately, both of these activities remain significant challenges, even with the current "state of the art" analytical instrumentation. The proposed work intends to develop a next-generation chiral analytical technique that is suitable for non-contact, rapid, accurate, and highly sensitive screening of chiral samples. This approach utilizes several experimentally simple, but scientifically sophisticated techniques from "state of the art" optics research first developed for nonlinear-optical spectroscopy, but which we now apply to simple polarimetry. The method transforms the detection of optical rotation into a dual-beam technique that utilizes the advantages of differential signal detection. In addition, the Faraday effect is utilized using a sinusoidally varying magnetic field on the sample, optical-heterodyne detection by modulating the laser source, and double modulation phase-sensitive detection. The addition of optical heterodyning decreases the observed background noise in the system by moving the signals of interest to frequencies where electronic pickup and optical noise in the system do not contribute (analogous to double-beam-double-modulation detection in laser absorption spectrometry). By observing analytical signals in electronically quiet regions, additional electronic gain can be applied prior to the analog-to-digital converter further improving system sensitivity. We call this set of techniques and the resulting device the Magneto-Optical Phase Enantiomeric Detector-Optical Rotation (MOPED). In the effort to discover and develop pharmaceutical candidates, one must consider that the vast majority of useful drugs have two or more potential geometrical forms. As the wrong geometrical form can cause harmful side effects, very high purity of therapeutics is essential for safe and effective treatment. The proposed work intends to develop a next-generation analytical technique that is suitable for non-contact, rapid, accurate, and highly sensitive screening of chiral geometries.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.